Thailand eyes status as AI medical hub

Thailand aims to establish itself as a regional hub for artificial intelligence (AI) in the medical field. This objective involves developing AI models tailored to Southeast Asian demographics, leveraging the country's clinical expertise, patient data, and research archives, and attracting private investment to bring innovations to market.

Deputy Prime Minister Yodchanan Wongsawat highlighted priorities such as building regional medical foundation models, AI-driven genomics, generative biology, autonomous discovery, longitudinal AI, human digital twins, and precision oncology. He emphasized the need for models that better accommodate the region's multicultural patient base and their unique clinical conditions.

Thailand's extensive university hospital tissue-imaging archives, spanning decades, could serve as a foundation for cancer research when combined with molecular biology and spatial transcriptomics. Generative biology and autonomous discovery could accelerate drug discovery processes. Longitudinal AI and human digital twins could aid in predicting risks for diseases like heart disease, diabetes, and kidney disease.

The country's demographic and behavioral diversity, coupled with its position as a medical destination, could attract international researchers. Thailand also seeks to adapt space and defense technologies for medical imaging equipment and vaccine machinery production. A nationwide consortium of university holding companies has been formed to foster collaboration, and technology licensing offices will assist startups and overseas partners in accessing intellectual property and turning research into products.

Support for this initiative will involve high-performance data centers, reliable energy supplies, and shared laboratories. The Southeast Asia Health Tech Innovation Hub, managed by SeaX Ventures, aims to accelerate clinical validation, hospital adoption, and market expansion.